Northrop Earnings Beat Wall Street Estimates. Why the Stock Is Down

Dow Jones
Jan 27

Northrop Grumman reported better-than-expected fourth-quarter earnings. Shares dropped, however. Expectations might have been too high.

Tuesday morning, the defense contractor reported fourth-quarter earnings per share of $7.23 from sales of $11.7 billion. Wall Street was looking for EPS of $6.98 from sales of $11.6 billion, according to FactSet. A year ago, Northrop reported EPS of $6.39 from sales of $10.7 billion. The backlog grew to a record $95.7 billion, with more orders than sales during the quarter.

Shares were down 2% at $648 in premarket trading, while S&P 500 futures were up 0.2% and Dow Jones Industrial Average futures were down 0.2%.

Starting points help explain the reaction. Northrop stock has been strong, boosted by higher growth from higher defense spending. Coming into Tuesday trading, Northrop shares were up 33% over the past 12 months. Gains left Northrop stock trading for about 23 times earnings estimated for the coming 12 months, up from about 18 times a year ago.

The company’s full-year outlook also landed a bit short of the Street consensus. For 2026, Northrop expects EPS of between $27.40 and $27.90. Analysis project $28.91. Sales are expected to land between $43.5 billion and $44 billion, up almost 5%. Wall Street, however, projects sales of $44.3 billion.

The operating profit guidance looks solid, though. Northrop expects about $4.9 billion, just ahead of the $4.8 billion analysts currently project.

Overall, the quarter looks OK, and the trends, such as higher sales growth, remain. Northrop grew sales closer to 3% a year between 2020 and 2025.

Things are better for the company these days. Some of that is reflected in the stock price.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10